PEPTIDE (VARIANTS) AND METHOD OF ITS PRODUCTION, PHARMACEUTICAL AGENT, ANTIBODY AND METHOD OF ITS PRODUCTION Russian patent published in 2002 - IPC

Abstract RU 2181379 C2

FIELD: immunology, biotechnology, peptides, pharmacy. SUBSTANCE: peptide shows the following amino acid sequence: ELDKWAS, LELDKWAS, ELDNWAS, ELNKWAS, LELDNWAS or LELNKWAS and promotes to the formation of antibodies. Peptide can be bound with a carrier as virus or viral protein. Peptide bound with a carrier is prepared by recombinant method. Antibody with HIV-1-neutralizing activity and secreted by mucosa envelope surface is prepared by immunization of human or animal. Invention ensures to develop a pharmaceutical agent promoting to the formation of antibodies to strains HIV-1 and/or clinical isolates. Invention can be used for preparing neutralizing antibodies raised to different strains and clinical isolates of HIV-1. EFFECT: improved method of peptide and antibody production. 17 cl, 9 dwg, 1 tbl, 7 ex

Similar patents RU2181379C2

Title Year Author Number
RECOMBINANT INFLUENZA VIRUS A 2001
  • Ferko Boris
  • Egorov Andrej Jur'Evich
  • Foglauehr Regina
RU2280690C2
PEPTIDE-SIMULATOR OF HUMAN IMMUNODEFICIENCY TYPE-1 VIRUS PROTEIN GP41 CONSERVATIVE EPITOPE RECOGNIZED BY VIRUS-NEUTRALIZING MONOCLONAL ANTIBODY 2F5 (VARIANTS) 2000
  • Tumanova O.Ju.
  • Kuvshinov V.N.
  • Melamed N.V.
  • Ushakova T.A.
  • Masharskij A.Eh.
  • Il'Ichev A.A.
  • Klimov N.A.
  • Kozlov A.P.
  • Sandakhchiev L.S.
RU2179980C2
RAPID SELECTION METHOD FOR HIV GP-120 VARIANTS 2012
  • Juste Errans Marija Eloiza
  • Sanches Merino Viktor
  • Ferrejra Karolina
RU2603732C2
VIRUS-LIKE PARTICLES WITH HIGH-DENSITY COATING FOR INDUCTION OF ANTIBODY EXPRESSION 2017
  • Carrillo Molina, Jorge
  • Molinos-Albert, Luis, M.
  • Blanco Arbues, Julian, M.
RU2813282C2
RECOMBINANT VIRUS-LIKE PARTICLES (VLP) USING BOVINE IMMUNODEFICIENCY VIRUS GROUP-SPECIFIC ANTIGEN (GAG) PROTEIN 2016
  • Pushko Piter
  • Tretyakova Irina
RU2734118C2
RECOMBINANT CHIMERICAL nTBI POLYPEPTIDE-IMMUNOGEN WITH ABILITY TO INDUCE NEUTRALIZING ANTIBODIES TO TYPE 1 HUMAN IMMUNODEFICIENCY VIRUS AND INTENDED FOR USE AS COMPONENT OF VACCINE AGAINST HIV-1 2016
  • Chikaev Anton Nikolaevich
  • Karpenko Larisa Ivanovna
  • Rudometov Andrej Pavlovich
  • Andreeva Nadezhda Borisovna
  • Ilichev Aleksandr Alekseevich
  • Shcherbakova Nadezhda Sergeevna
RU2642258C1
ROTAVIRAL PARTICLES WITH CHIMERIC SURFACE PROTEINS 2014
  • Dormittser Filip R.
  • Grigorieff Nikolaus
  • Kharrison Stefen
  • Pan Tszyunkhua
  • Settembre Itan
RU2698049C2
RECOMBINANT VACCINE STRAIN FOR LIVE INTRANASAL VACCINE PROVIDING COMBINED PREVENTION OF INFLUENZA AND CORONAVIRUS INFECTIONS 2022
  • Isakova-Sivan Irina Nikolaevna
  • Stepanova Ekaterina Alekseevna
  • Mezhenskaya Darya Andreevna
  • Matyushenko Viktoriya Arkadevna
  • Rudenko Larisa Georgievna
RU2782531C1
METHODS AND COMPOSITION FOR INHIBITION OF HIV-1 MULTIPLICATION 2001
  • Gol'Dshtejn Gideon
RU2275379C2
ARTIFICIAL YkuJ-MPER GENE ENCODING YkuJ-MPER RECOMBINANT PROTEIN-IMMUNOGEN, pET21a-YkuJ-MPER RECOMBINANT PLASMID DNA, PROVIDING EXPRESSION OF ARTIFICIAL YkuJ-MPER GENE, AND YkuJ-MPER RECOMBINANT PROTEIN-IMMUNOGEN, WHICH IS CARRIER OF MEMBRANE-PROXIMAL AREA OF HIV-1 AND INTENDED FOR INDUCTION IN BROADLY NEUTRALIZING ANTIBODIES 2017
  • Rudometov Andrej Pavlovich
  • Andreeva Nadezhda Borisovna
  • Shcherbakov Dmitrij Nikolaevich
  • Karpenko Larisa Ivanovna
  • Bakulina Anastasiya Yurevna
RU2679076C1

RU 2 181 379 C2

Authors

Khermann Katinger

Tomas Muster

Dates

2002-04-20Published

1994-09-12Filed